Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. Look up trials for lymphoma or CLL by clicking a map

   By Guest guest, February 4, 2011
   • 0 replies
   • 36 views
   • 
   • Guest
   • February 4, 2011

2. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

   By Guest guest, February 3, 2011
   • 0 replies
   • 40 views
   • 
   • Guest
   • February 3, 2011

3. The fallibility of expert opinion ahead of evidence from RCTs

   By Guest guest, February 2, 2011
   • 1 reply
   • 19 views
   • 
   • Guest
   • February 2, 2011

4. molecularly tailored maintenance therapy?

   By Guest guest, April 14, 2011
   • 0 replies
   • 24 views
   • 
   • Guest
   • April 14, 2011

5. Modified Chemotherapy Regimen Offers New Treatment Option For Very Elderly Patients With Aggressive Type Of Non-Hodgkin's Lymphoma

   By Guest guest, April 14, 2011
   • 0 replies
   • 26 views
   • 
   • Guest
   • April 14, 2011

6. Dr. Link on ongoing drug shortage crisis

   By Guest guest, January 30, 2011
   • 0 replies
   • 34 views
   • 
   • Guest
   • January 30, 2011

7. NEJM: followup on vitamin D

   By Guest guest, April 14, 2011
   • 0 replies
   • 29 views
   • 
   • Guest
   • April 14, 2011

8. regarding CER

   By Guest guest, April 14, 2011
   • 0 replies
   • 23 views
   • 
   • Guest
   • April 14, 2011

9. study of interest: CAL101 for refractory indolent NHL/SLL

   By Guest guest, January 30, 2011
   • 0 replies
   • 28 views
   • 
   • Guest
   • January 30, 2011

10. Emergent initiates Phase Ib/II chronic lymphocytic leukemia study

    By Guest guest, January 31, 2011
    • 0 replies
    • 39 views
    • 
    • Guest
    • January 31, 2011

11. Treatment-Related Questions for Your Doctor

    By Guest guest, April 13, 2011
    • 0 replies
    • 23 views
    • 
    • Guest
    • April 13, 2011

12. ImmunoGen, Inc. Announces First Data For Its IMGN529 Product Candidate For Non-Hodgkin's Lymphoma

    By Guest guest, April 8, 2011
    • 0 replies
    • 24 views
    • 
    • Guest
    • April 8, 2011

13. How to report a drug shortage by email, phone, or web

    By Guest guest, February 1, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • February 1, 2011

14. Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

    By Guest guest, February 5, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • February 5, 2011

15. SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70

    By Guest guest, February 7, 2011
    • 0 replies
    • 28 views
    • 
    • Guest
    • February 7, 2011

16. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.

    By Guest guest, February 7, 2011
    • 0 replies
    • 31 views
    • 
    • Guest
    • February 7, 2011

17. CCL3 (MIP-1(alpha)) plasma levels and the risk for disease progression in chronic lymphocytic leukemia

    By Guest guest, February 7, 2011
    • 0 replies
    • 31 views
    • 
    • Guest
    • February 7, 2011

18. Novel therapeutic agents for B-cell lymphoma: developing rational combinations

    By Guest guest, February 7, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • February 7, 2011

19. Chromosomal study for prognostic grouping in chronic lymphocytic leukemia.

    By Guest guest, February 8, 2011
    • 0 replies
    • 20 views
    • 
    • Guest
    • February 8, 2011

20. Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells.

    By Guest guest, February 8, 2011
    • 0 replies
    • 31 views
    • 
    • Guest
    • February 8, 2011

21. Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy

    By Guest guest, February 8, 2011
    • 0 replies
    • 39 views
    • 
    • Guest
    • February 8, 2011

22. The spectrum of use of rituximab in chronic lymphocytic leukemia

    By Guest guest, February 8, 2011
    • 0 replies
    • 29 views
    • 
    • Guest
    • February 8, 2011

23. FW: FDA MedWatch - Revlimid (lenalidomide): Ongoing Safety Review - increased risk of developing new malignancies

    By Guest guest, April 9, 2011
    • 0 replies
    • 30 views
    • 
    • Guest
    • April 9, 2011

24. Just a reminder about our trial lookup resource

    By Guest guest, April 10, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • April 10, 2011

25. DL-Derived octopus Antibodies

    By Guest guest, April 11, 2011
    • 0 replies
    • 75 views
    • 
    • Guest
    • April 11, 2011